LAB.00035 Multi-biomarker Disease Activity Blood Tests for Rheumatoid Arthritis Form
Procedure is not covered
This document addresses the use of multi-biomarker disease activity (MBDA) blood testing that produces a score designed to assess rheumatoid arthritis (RA) disease activity. An example is the Vectra® DA blood test (Crescendo Bioscience, Inc., South San Francisco, CA).
Position Statement
Investigational and Not Medically Necessary:
The use of multi-biomarker disease activity blood testing for rheumatoid arthritis (for example, Vectra DA) is considered investigational and not medically necessary in all situations.
Book a walkthrough
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.
Loading available demo times